The Coriell Institute for Medical Research, a nonprofit biomedical research organization based in Camden, NJ, is committed to providing the global scientific community with high-quality and well-characterized biomaterials, including a wide array of induced pluripotent stem cells. As the trusted steward of world-renowned biorepositories for the National Institutes of Health, disease foundations and commercial clients, Coriell stores and distributes biospecimens from some of the most diverse collections of diseased and healthy human populations in the world. The Institute also offers a multitude of scientific services to meet the growing needs of the biomedical research community. Each of these products and services meets Coriell’s industry-leading, ISO 9001:2015 certified quality control and quality assurance standards and many are customizable. Coriell is recognized as a leader in the field of personalized medicine. Through the Coriell Personalized Medicine Collaborative (CPMC), Coriell’s scientists are investigating how information about a person’s genetics can affect decisions about their health. The CPMC is a model for the ethical, legal, and responsible implementation of best practices in personalized medicine. Aside from contributing to scientific literature, CPMC researchers also help educate the medical and lay communities about the usefulness of personalized medicine to support its integration into healthcare delivery. Coriell scientists are leveraging their genomic expertise to help develop new tools to prevent and treat opioid use disorder. Learn more.